Clinical operations field note

5 Warning Signs an Oncology Trial Needs More Staff

Spot five signs of a clinical operations capacity gap, from missed milestones and monitoring coverage to growing trial master file backlogs.

By Lampgen Clinical Research

Five Capacity Warning Signs
  1. 1. Milestones are repeatedly recovered instead of proactively managed. Constant rescue work is a capacity signal.
  2. 2. One CTM is carrying too many studies, vendors, or escalation pathways. Oversight quality falls when everything becomes urgent.
  3. 3. Monitoring coverage no longer reflects site risk. Low-risk and high-risk sites cannot receive the same attention by default.
  4. 4. TMF reconciliation keeps moving to the end of the priority list. Documentation debt becomes inspection risk.
  5. 5. Enrollment is accelerating faster than oversight capacity. More patients create more data, safety, monitoring, and coordination pressure.

Clinical studies rarely become under-resourced in one dramatic moment.

The warning signs usually appear earlier: recurring rescue work, delayed follow-up, strained CTMs, uneven monitoring coverage, and documentation that keeps getting pushed to later.

Each problem may look manageable by itself.

Together, they show that study complexity is beginning to exceed team capacity.

The right time to add support is before a missed milestone, inspection concern, or resignation forces the decision.

Which warning sign tends to appear first on a growing oncology program?

Review workload around the next milestone

Start with the work due over the coming weeks: monitoring visits and follow-up, vendor decisions, site activation, data review, essential documentation, and internal approvals. Assign an owner and identify the dependencies for each item.

Compare the work with available time and relevant experience. Look for the same person appearing as the owner, reviewer, and backup across several critical activities. A full calendar alone does not tell you which work is at risk.

Use a practical capacity check

  • Which work is repeatedly moved to a later date?
  • Which overdue actions affect another team’s ability to proceed?
  • Does monitoring coverage reflect the current site and enrollment workload?
  • Is one person the only available owner of a critical decision or process?
  • What changes in workload after the next planned study milestone?
  • What could be reassigned, simplified, or better defined before adding support?

Choose support around the work

A gap in visit coverage and site follow-up may point to CRA support. Recurring coordination and monitoring-quality needs may call for Lead CRA support. A gap in study-level decisions, vendor coordination, or milestone oversight may call for a CTM discussion.

These are planning considerations rather than fixed staffing ratios. Define the actual responsibilities, internal oversight, and duration before choosing a title or engagement model.

Planning example

Imagine a study adding sites while enrollment increases. The headline milestone may appear on track, while report review and site action follow-up move later each week. Review the pending work and ownership before deciding whether the immediate need is additional monitoring capacity, coordination, or a study-management assignment.

Bring that workload map to the staffing discussion. It gives both sides a more useful starting point than an urgent request for ‘another person.’

AVAILABLE FOR NEW PARTNERSHIPS

What does your clinical team need next?